Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
NasdaqGS - Nasdaq Real Time Price USD

Standard BioTools Inc. (LAB)

Compare
1.0700
-0.1100
(-9.32%)
At close: April 3 at 4:00:02 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
174,432
174,432
106,340
97,948
130,581
Cost of Revenue
90,170
90,170
55,890
60,897
61,208
Gross Profit
84,262
84,262
50,450
37,051
69,373
Operating Expense
219,019
219,019
113,489
139,667
136,832
Operating Income
-134,757
-134,757
-63,039
-102,616
-67,459
Net Non Operating Interest Income Expense
16,883
16,883
1,005
-2,105
-3,823
Other Income Expense
-20,438
-20,438
-12,170
-88,207
7,622
Pretax Income
-138,312
-138,312
-74,204
-192,928
-63,660
Tax Provision
573
573
452
-2,830
-4,423
Net Income Common Stockholders
-184,899
-184,899
-74,656
-190,098
-59,237
Diluted NI Available to Com Stockholders
-184,899
-184,899
-74,656
-190,098
-59,237
Basic EPS
-0.69
-0.52
-0.94
-2.43
-0.78
Diluted EPS
-0.69
-0.52
-0.94
-2.43
-0.78
Basic Average Shares
279,504.5000
353,245
79,160
78,305
75,786
Diluted Average Shares
279,504.5000
353,245
79,160
78,305
75,786
Total Operating Income as Reported
-175,236
-175,236
-76,600
-116,205
-67,459
Total Expenses
309,189
309,189
169,379
200,564
198,040
Net Income from Continuing & Discontinued Operation
-138,885
-138,885
-74,656
-190,098
-59,237
Normalized Income
-126,824.8600
-126,824.8600
-63,942.8100
-117,533.0500
-59,237
Interest Income
20,199
20,199
5,572
2,226
--
Interest Expense
3,316
3,316
4,567
4,331
3,823
Net Interest Income
16,883
16,883
1,005
-2,105
-3,823
EBIT
-134,996
-134,996
-69,637
-188,597
-59,837
EBITDA
-118,135
-118,135
-54,457
-173,570
-44,266
Reconciled Cost of Revenue
90,170
90,170
55,890
60,897
61,208
Reconciled Depreciation
16,861
16,861
15,180
15,027
15,571
Net Income from Continuing Operation Net Minority Interest
-138,885
-138,885
-74,656
-190,098
-59,237
Total Unusual Items Excluding Goodwill
-15,266
-15,266
-13,561
-73,670
-9
Total Unusual Items
-15,266
-15,266
-13,561
-73,670
-9
Normalized EBITDA
-102,869
-102,869
-40,896
-99,900
-44,266
Tax Rate for Calcs
0.0002
0.0002
0.0002
0
0.0001
Tax Effect of Unusual Items
-3,205.8600
-3,205.8600
-2,847.8100
-1,105.0500
--
12/31/2021 - 2/10/2011

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

QTRX Quanterix Corporation
6.21
-7.59%
 
CTKB Cytek Biosciences, Inc.
3.7200
-6.77%
 
CHEMM.CO ChemoMetec A/S
438.80
-5.55%
 
MODD Modular Medical, Inc.
0.9731
-6.43%
 
NPCE NeuroPace, Inc.
13.01
-3.91%
 
BBLG Bone Biologics Corporation
0.8600
+1.91%
 
XTNT Xtant Medical Holdings, Inc.
0.4701
+0.02%
 
FNA Paragon 28, Inc.
13.07
-0.08%
 
SGHT Sight Sciences, Inc.
2.2300
-0.89%
 
LIVN LivaNova PLC
37.48
-5.11%